{
  "ticker": "QURE",
  "company_name": "uniQure N.V.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06063850",
      "title": "AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Mesial Temporal Lobe Epilepsy",
      "start_date": "2024-06-12",
      "completion_date": "2031-12",
      "enrollment": 0,
      "sponsor": "UniQure Biopharma B.V."
    },
    {
      "nct_id": "NCT04120493",
      "title": "Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Huntington's Disease",
      "start_date": "2019-09-06",
      "completion_date": "2029-12",
      "enrollment": 0,
      "sponsor": "UniQure Biopharma B.V."
    },
    {
      "nct_id": "NCT03300453",
      "title": "Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Sanfilippo Syndrome B",
      "start_date": "2013-09-17",
      "completion_date": "2019-11-27",
      "enrollment": 0,
      "sponsor": "UniQure Biopharma B.V."
    },
    {
      "nct_id": "NCT06270316",
      "title": "Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Fabry Disease",
      "start_date": "2024-06-05",
      "completion_date": "2031-04-30",
      "enrollment": 0,
      "sponsor": "UniQure Biopharma B.V."
    },
    {
      "nct_id": "NCT06100276",
      "title": "Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Amyotrophic Lateral Sclerosis",
      "start_date": "2024-08-01",
      "completion_date": "2031-06-30",
      "enrollment": 0,
      "sponsor": "UniQure Biopharma B.V."
    },
    {
      "nct_id": "NCT04723680",
      "title": "An Exploration of the Impact of Gene Therapy on the Lives of People With Haemophilia and Their Families",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Hemophilia",
      "start_date": "2020-08-13",
      "completion_date": "2023-02-28",
      "enrollment": 0,
      "sponsor": "Haemnet"
    },
    {
      "nct_id": "NCT02904772",
      "title": "Alipogene Tiparvovec for the Treatment of LPLD Patients",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "LPL Deficiency",
      "start_date": "2016-10",
      "completion_date": "2020-09",
      "enrollment": 0,
      "sponsor": "UniQure Biopharma B.V."
    },
    {
      "nct_id": "NCT03293810",
      "title": "Glybera Registry, Lipoprotein Lipase Deficient (LPLD) Patients",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Lipoprotein Lipase Deficiency, Familial Hyperlipoproteinemia Type 1, Familial Hyperchylomicronemia",
      "start_date": "2014-06-27",
      "completion_date": "2023-06",
      "enrollment": 0,
      "sponsor": "UniQure Biopharma B.V."
    },
    {
      "nct_id": "NCT05243017",
      "title": "Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Huntington Disease",
      "start_date": "2021-10-07",
      "completion_date": "2029-10-07",
      "enrollment": 0,
      "sponsor": "UniQure Biopharma B.V."
    },
    {
      "nct_id": "NCT02076763",
      "title": "Observational Study of Acute Intermittent Porphyria Patients",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Acute Intermittent Porphyria",
      "start_date": "2011-08",
      "completion_date": "2014-02",
      "enrollment": 0,
      "sponsor": "Digna Biotech S.L."
    }
  ],
  "summary": {
    "total_trials": 11,
    "by_phase": {
      "PHASE1, PHASE2": 6,
      "": 3,
      "PHASE2": 1,
      "PHASE1": 1
    },
    "by_status": {
      "RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 3,
      "COMPLETED": 5,
      "WITHDRAWN": 1
    },
    "active_trials": 5,
    "completed_trials": 5,
    "conditions": [
      "Acute Intermittent Porphyria",
      "Amyotrophic Lateral Sclerosis",
      "Fabry Disease",
      "Hemophilia",
      "Huntington Disease",
      "Huntington's Disease",
      "LPL Deficiency",
      "Lipoprotein Lipase Deficiency, Familial Hyperlipoproteinemia Type 1, Familial Hyperchylomicronemia",
      "Mesial Temporal Lobe Epilepsy",
      "Sanfilippo Syndrome B"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:15.193318",
    "search_query": "uniQure N.V.",
    "url": "https://clinicaltrials.gov/search?term=uniQure+N.V."
  }
}